This report contains market size and forecasts of Dermatology OTC Medications in global, including the following market information:
Global Dermatology OTC Medications Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Dermatology OTC Medications Market Sales, 2016-2021, 2022-2027, (M Units)
Global top five Dermatology OTC Medications companies in 2020 (%)
The global Dermatology OTC Medications market was valued at 12770 million in 2020 and is projected to reach US$ 14460 million by 2027, at a CAGR of 3.2% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dermatology OTC Medications manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dermatology OTC Medications Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Units)
Global Dermatology OTC Medications Market Segment Percentages, By Type, 2020 (%)
External Use
Oral
Global Dermatology OTC Medications Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Units)
Global Dermatology OTC Medications Market Segment Percentages, By Application, 2020 (%)
Hospital
Drug Store
Other
Global Dermatology OTC Medications Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (M Units)
Global Dermatology OTC Medications Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dermatology OTC Medications revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Dermatology OTC Medications revenues share in global market, 2020 (%)
Key companies Dermatology OTC Medications sales in global market, 2016-2021 (Estimated), (M Units)
Key companies Dermatology OTC Medications sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
GSK
Teva
Johnson & Johnson
Novartis
Mylan
Sun Pharmaceutical
Aurobindo
Galderma
CR SANJIU
Dr. Reddy's
Lupin
Bausch Health
Cipla
Qilu Pharmaceutical
Almirall
Lingrui
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Dermatology OTC Medications Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dermatology OTC Medications Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dermatology OTC Medications Overall Market Size
2.1 Global Dermatology OTC Medications Market Size: 2021 VS 2027
2.2 Global Dermatology OTC Medications Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Dermatology OTC Medications Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Dermatology OTC Medications Players in Global Market
3.2 Top Global Dermatology OTC Medications Companies Ranked by Revenue
3.3 Global Dermatology OTC Medications Revenue by Companies
3.4 Global Dermatology OTC Medications Sales by Companies
3.5 Global Dermatology OTC Medications Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Dermatology OTC Medications Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Dermatology OTC Medications Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dermatology OTC Medications Players in Global Market
3.8.1 List of Global Tier 1 Dermatology OTC Medications Companies
3.8.2 List of Global Tier 2 and Tier 3 Dermatology OTC Medications Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Dermatology OTC Medications Market Size Markets, 2021 & 2027
4.1.2 External Use
4.1.3 Oral
4.2 By Type - Global Dermatology OTC Medications Revenue & Forecasts
4.2.1 By Type - Global Dermatology OTC Medications Revenue, 2016-2021
4.2.2 By Type - Global Dermatology OTC Medications Revenue, 2022-2027
4.2.3 By Type - Global Dermatology OTC Medications Revenue Market Share, 2016-2027
4.3 By Type - Global Dermatology OTC Medications Sales & Forecasts
4.3.1 By Type - Global Dermatology OTC Medications Sales, 2016-2021
4.3.2 By Type - Global Dermatology OTC Medications Sales, 2022-2027
4.3.3 By Type - Global Dermatology OTC Medications Sales Market Share, 2016-2027
4.4 By Type - Global Dermatology OTC Medications Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Dermatology OTC Medications Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Drug Store
5.1.4 Other
5.2 By Application - Global Dermatology OTC Medications Revenue & Forecasts
5.2.1 By Application - Global Dermatology OTC Medications Revenue, 2016-2021
5.2.2 By Application - Global Dermatology OTC Medications Revenue, 2022-2027
5.2.3 By Application - Global Dermatology OTC Medications Revenue Market Share, 2016-2027
5.3 By Application - Global Dermatology OTC Medications Sales & Forecasts
5.3.1 By Application - Global Dermatology OTC Medications Sales, 2016-2021
5.3.2 By Application - Global Dermatology OTC Medications Sales, 2022-2027
5.3.3 By Application - Global Dermatology OTC Medications Sales Market Share, 2016-2027
5.4 By Application - Global Dermatology OTC Medications Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Dermatology OTC Medications Market Size, 2021 & 2027
6.2 By Region - Global Dermatology OTC Medications Revenue & Forecasts
6.2.1 By Region - Global Dermatology OTC Medications Revenue, 2016-2021
6.2.2 By Region - Global Dermatology OTC Medications Revenue, 2022-2027
6.2.3 By Region - Global Dermatology OTC Medications Revenue Market Share, 2016-2027
6.3 By Region - Global Dermatology OTC Medications Sales & Forecasts
6.3.1 By Region - Global Dermatology OTC Medications Sales, 2016-2021
6.3.2 By Region - Global Dermatology OTC Medications Sales, 2022-2027
6.3.3 By Region - Global Dermatology OTC Medications Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Dermatology OTC Medications Revenue, 2016-2027
6.4.2 By Country - North America Dermatology OTC Medications Sales, 2016-2027
6.4.3 US Dermatology OTC Medications Market Size, 2016-2027
6.4.4 Canada Dermatology OTC Medications Market Size, 2016-2027
6.4.5 Mexico Dermatology OTC Medications Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Dermatology OTC Medications Revenue, 2016-2027
6.5.2 By Country - Europe Dermatology OTC Medications Sales, 2016-2027
6.5.3 Germany Dermatology OTC Medications Market Size, 2016-2027
6.5.4 France Dermatology OTC Medications Market Size, 2016-2027
6.5.5 U.K. Dermatology OTC Medications Market Size, 2016-2027
6.5.6 Italy Dermatology OTC Medications Market Size, 2016-2027
6.5.7 Russia Dermatology OTC Medications Market Size, 2016-2027
6.5.8 Nordic Countries Dermatology OTC Medications Market Size, 2016-2027
6.5.9 Benelux Dermatology OTC Medications Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Dermatology OTC Medications Revenue, 2016-2027
6.6.2 By Region - Asia Dermatology OTC Medications Sales, 2016-2027
6.6.3 China Dermatology OTC Medications Market Size, 2016-2027
6.6.4 Japan Dermatology OTC Medications Market Size, 2016-2027
6.6.5 South Korea Dermatology OTC Medications Market Size, 2016-2027
6.6.6 Southeast Asia Dermatology OTC Medications Market Size, 2016-2027
6.6.7 India Dermatology OTC Medications Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Dermatology OTC Medications Revenue, 2016-2027
6.7.2 By Country - South America Dermatology OTC Medications Sales, 2016-2027
6.7.3 Brazil Dermatology OTC Medications Market Size, 2016-2027
6.7.4 Argentina Dermatology OTC Medications Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Dermatology OTC Medications Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Dermatology OTC Medications Sales, 2016-2027
6.8.3 Turkey Dermatology OTC Medications Market Size, 2016-2027
6.8.4 Israel Dermatology OTC Medications Market Size, 2016-2027
6.8.5 Saudi Arabia Dermatology OTC Medications Market Size, 2016-2027
6.8.6 UAE Dermatology OTC Medications Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Bayer
7.1.1 Bayer Corporate Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Dermatology OTC Medications Major Product Offerings
7.1.4 Bayer Dermatology OTC Medications Sales and Revenue in Global (2016-2021)
7.1.5 Bayer Key News
7.2 GSK
7.2.1 GSK Corporate Summary
7.2.2 GSK Business Overview
7.2.3 GSK Dermatology OTC Medications Major Product Offerings
7.2.4 GSK Dermatology OTC Medications Sales and Revenue in Global (2016-2021)
7.2.5 GSK Key News
7.3 Teva
7.3.1 Teva Corporate Summary
7.3.2 Teva Business Overview
7.3.3 Teva Dermatology OTC Medications Major Product Offerings
7.3.4 Teva Dermatology OTC Medications Sales and Revenue in Global (2016-2021)
7.3.5 Teva Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Dermatology OTC Medications Major Product Offerings
7.4.4 Johnson & Johnson Dermatology OTC Medications Sales and Revenue in Global (2016-2021)
7.4.5 Johnson & Johnson Key News
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Dermatology OTC Medications Major Product Offerings
7.5.4 Novartis Dermatology OTC Medications Sales and Revenue in Global (2016-2021)
7.5.5 Novartis Key News
7.6 Mylan
7.6.1 Mylan Corporate Summary
7.6.2 Mylan Business Overview
7.6.3 Mylan Dermatology OTC Medications Major Product Offerings
7.6.4 Mylan Dermatology OTC Medications Sales and Revenue in Global (2016-2021)
7.6.5 Mylan Key News
7.7 Sun Pharmaceutical
7.7.1 Sun Pharmaceutical Corporate Summary
7.7.2 Sun Pharmaceutical Business Overview
7.7.3 Sun Pharmaceutical Dermatology OTC Medications Major Product Offerings
7.4.4 Sun Pharmaceutical Dermatology OTC Medications Sales and Revenue in Global (2016-2021)
7.7.5 Sun Pharmaceutical Key News
7.8 Aurobindo
7.8.1 Aurobindo Corporate Summary
7.8.2 Aurobindo Business Overview
7.8.3 Aurobindo Dermatology OTC Medications Major Product Offerings
7.8.4 Aurobindo Dermatology OTC Medications Sales and Revenue in Global (2016-2021)
7.8.5 Aurobindo Key News
7.9 Galderma
7.9.1 Galderma Corporate Summary
7.9.2 Galderma Business Overview
7.9.3 Galderma Dermatology OTC Medications Major Product Offerings
7.9.4 Galderma Dermatology OTC Medications Sales and Revenue in Global (2016-2021)
7.9.5 Galderma Key News
7.10 CR SANJIU
7.10.1 CR SANJIU Corporate Summary
7.10.2 CR SANJIU Business Overview
7.10.3 CR SANJIU Dermatology OTC Medications Major Product Offerings
7.10.4 CR SANJIU Dermatology OTC Medications Sales and Revenue in Global (2016-2021)
7.10.5 CR SANJIU Key News
7.11 Dr. Reddy's
7.11.1 Dr. Reddy's Corporate Summary
7.11.2 Dr. Reddy's Dermatology OTC Medications Business Overview
7.11.3 Dr. Reddy's Dermatology OTC Medications Major Product Offerings
7.11.4 Dr. Reddy's Dermatology OTC Medications Sales and Revenue in Global (2016-2021)
7.11.5 Dr. Reddy's Key News
7.12 Lupin
7.12.1 Lupin Corporate Summary
7.12.2 Lupin Dermatology OTC Medications Business Overview
7.12.3 Lupin Dermatology OTC Medications Major Product Offerings
7.12.4 Lupin Dermatology OTC Medications Sales and Revenue in Global (2016-2021)
7.12.5 Lupin Key News
7.13 Bausch Health
7.13.1 Bausch Health Corporate Summary
7.13.2 Bausch Health Dermatology OTC Medications Business Overview
7.13.3 Bausch Health Dermatology OTC Medications Major Product Offerings
7.13.4 Bausch Health Dermatology OTC Medications Sales and Revenue in Global (2016-2021)
7.13.5 Bausch Health Key News
7.14 Cipla
7.14.1 Cipla Corporate Summary
7.14.2 Cipla Business Overview
7.14.3 Cipla Dermatology OTC Medications Major Product Offerings
7.14.4 Cipla Dermatology OTC Medications Sales and Revenue in Global (2016-2021)
7.14.5 Cipla Key News
7.15 Qilu Pharmaceutical
7.15.1 Qilu Pharmaceutical Corporate Summary
7.15.2 Qilu Pharmaceutical Business Overview
7.15.3 Qilu Pharmaceutical Dermatology OTC Medications Major Product Offerings
7.15.4 Qilu Pharmaceutical Dermatology OTC Medications Sales and Revenue in Global (2016-2021)
7.15.5 Qilu Pharmaceutical Key News
7.16 Almirall
7.16.1 Almirall Corporate Summary
7.16.2 Almirall Business Overview
7.16.3 Almirall Dermatology OTC Medications Major Product Offerings
7.16.4 Almirall Dermatology OTC Medications Sales and Revenue in Global (2016-2021)
7.16.5 Almirall Key News
7.17 Lingrui
7.17.1 Lingrui Corporate Summary
7.17.2 Lingrui Business Overview
7.17.3 Lingrui Dermatology OTC Medications Major Product Offerings
7.17.4 Lingrui Dermatology OTC Medications Sales and Revenue in Global (2016-2021)
7.17.5 Lingrui Key News
8 Global Dermatology OTC Medications Production Capacity, Analysis
8.1 Global Dermatology OTC Medications Production Capacity, 2016-2027
8.2 Dermatology OTC Medications Production Capacity of Key Manufacturers in Global Market
8.3 Global Dermatology OTC Medications Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Dermatology OTC Medications Supply Chain Analysis
10.1 Dermatology OTC Medications Industry Value Chain
10.2 Dermatology OTC Medications Upstream Market
10.3 Dermatology OTC Medications Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Dermatology OTC Medications Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Dermatology OTC Medications in Global Market
Table 2. Top Dermatology OTC Medications Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Dermatology OTC Medications Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Dermatology OTC Medications Revenue Share by Companies, 2016-2021
Table 5. Global Dermatology OTC Medications Sales by Companies, (M Units), 2016-2021
Table 6. Global Dermatology OTC Medications Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Dermatology OTC Medications Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Dermatology OTC Medications Product Type
Table 9. List of Global Tier 1 Dermatology OTC Medications Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dermatology OTC Medications Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type